Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

CEO Hock Tan Sold 7,500 Shares of Broadcom (AVGO) Stock

By Josh Enomoto, InvestorPlace Contributor

Although Broadcom has been on a blistering run this year, the recent insider sell may impose a wrinkle onto AVGO stock.

Trade of the Day: Buy Rumble (RUM) Stock Call Options as Trump Trades Gain

By Josh Enomoto, InvestorPlace Contributor

The Trump assassination attempt sparked global headlines and created a rally in Trump-linked equities like Rumble and RUM stock.

TD Cowen Just Raised Its Price Target on Nvidia (NVDA) Stock

By Josh Enomoto, InvestorPlace Contributor

Although Nvidia has encountered choppy conditions recently, TD Cowen analysts believe that NVDA stock still has room to run.

G1 Therapeutics Stock: The Undervalued Gem Poised for a 30% Revenue Surge by 2025

By Josh Enomoto, InvestorPlace Contributor

While there’s no denying that G1 Therapeutics stock is highly speculative, investors should still check under the hood.

Why Is Autonomix Medical (AMIX) Stock Up 120% Today?

By Josh Enomoto, InvestorPlace Contributor

A licensing agreement brings credibility and opportunity for Autonomix Medical, sending AMIX stock soaring despite a risky profile.

Load More